• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION ABACUS V3.1 SE (8300-0168)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION ABACUS V3.1 SE (8300-0168) Back to Search Results
Model Number 8300-0168
Device Problem Use of Device Problem (1670)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
This issue was resolved through assistance provided by baxter technical support (bts).Based on the customer report and troubleshooting performed by bts, this event was determined to be use error.Per the abacus user guide, serious harm or death may occur if an adequate review isn't completed.The abacus software changes an order to complete only after an authorized user completely finishes and approves an order.A thorough review of all data on each tab in the order entry process will minimize the risk of medication error.This complaint is logged as complaint file number (b)(4).
 
Event Description
It was reported that during tpn order creation using abacus software, the customer had inadvertently ordered dextrose 15% instead of dextrose 10%.This tpn order was produced, released, and infused on a nicu patient.There was no report of patient injury, adverse event, or medical intervention in relation to this event.During troubleshooting by baxter technical support (bts), it was discovered that while using a stock template in abacus for dextrose 10% orders, the user had changed the dextrose concentration to 15% for one order but then failed to change the concentration back to 10% before entering subsequent orders.A pharmacist had reviewed the orders but failed to notice the discrepancy.Bts helped the customer lock the dextrose 10% and 5% templates in order to disable the option to modify the concentration during order entry.The customer was also instructed to contact bts any time a new concentration template needs to be created.No additional information.Report 5 of 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABACUS V3.1 SE (8300-0168)
Type of Device
ABACUS V3.1 SE (8300-0168)
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
14445 grasslands drive
englewood CO 80112
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
14445 grasslands drive
englewood CO 80112
Manufacturer Contact
toni cruz
9540 s maroon circle
suite 400
englewood, CO 80112
3033909898
MDR Report Key5508993
MDR Text Key40637681
Report Number1419106-2016-00123
Device Sequence Number1
Product Code JQP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number8300-0168
Device Catalogue Number8300-0168
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/18/2016
Initial Date FDA Received03/17/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Age5 DA
Patient Weight3
-
-